Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Haematologica|February 27, 2025
Prognostic relevance of variant allelic frequency for treatment outcomes in patients with acute myeloid leukemia: a study by the Spanish PETHEMA registryRafael Colmenares, Noemi Alvarez, Eva Barragan, et al.
American Journal of Hematology|June 30, 2026
Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II TrialTeresa Bernal, Javier Zambrano Márquez, Rebeca Rodríguez-Veiga, et al.
Leukemia|February 2, 2021
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemiaBruno Paiva, María-Belen Vidriales, Amparo Sempere, et al.
Scientific Reports|October 21, 2021
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimensTamara Castaño-Bonilla, Juan M Alonso-Dominguez, Eva Barragán, et al.
Cancers|January 21, 2023
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA RegistryClaudia Sargas, Rosa Ayala, María José Larráyoz, et al.
Haematologica|May 18, 2023
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registryDavid Martínez-Cuadrón, Juan E Megías-Vericat, Cristina Gil, et al.
Cancer|June 19, 2024
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA RegistryJorge Labrador, David Martínez-Cuadrón, Blanca Boluda, et al.
Leukemia|October 20, 2020
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?David Martínez-Cuadrón, Josefina Serrano, Cristina Gil, et al.
Blood Advances|November 18, 2021
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry studyDavid Martínez-Cuadrón, Juan E Megías-Vericat, Josefina Serrano, et al.
Hematological Oncology|January 9, 2026
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA RegistryEsther Prados de la Torre, Josefina Serrano, Eva Barragán, et al.
Pageof 9